ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

BSGM BioSig Technologies Inc

1,32
0,02 (1,54%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
BioSig Technologies Inc BSGM NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,02 1,54% 1,32 01:39:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,31 1,2701 1,39 1,37 1,30
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
04.4.202417:35GLOBEBioSig Engages Consulting Firm for Business Model Strategies
11.3.202414:00EDGAR2Form 8-K - Current report
05.3.202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202415:00EDGAR2Form 8-K - Current report
20.2.202416:00GLOBEBioSig Announces Reduction of its Workforce
14.2.202421:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06.2.202414:35EDGAR2Form 8-K - Current report
06.2.202414:30GLOBEBioSig’s PURE EP™ Platform with New Near Field Tracking..
02.2.202423:18EDGAR2Form 8-K/A - Current report: [Amend]
01.2.202423:25EDGAR2Form 8-K - Current report
31.1.202422:05EDGAR2Form 8-K - Current report
31.1.202417:15GLOBEBioSig Announces Reverse Stock Split
30.1.202414:52EDGAR2Form 8-K - Current report
30.1.202414:30GLOBEBioSig Announces Cost Reductions to Improve its Financial..
16.1.202422:15EDGAR2Form D - Notice of Exempt Offering of Securities
12.1.202423:28EDGAR2Form 8-K - Current report
08.1.202417:00EDGAR2Form 8-K - Current report
05.1.202422:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
04.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202319:37EDGAR2Form DEL AM - Delaying amendment
28.12.202322:30EDGAR2Form 8-K - Current report
28.12.202322:05EDGAR2Form S-3 - Registration statement under Securities Act of..
22.12.202322:30EDGAR2Form 8-K - Current report
18.12.202322:36EDGAR2Form 8-K - Current report
06.12.202323:07EDGAR2Form 8-K - Current report
06.12.202320:20GLOBEBioSig Issues Letter to Shareholders Detailing Technology..
05.12.202323:29EDGAR2Form 8-K - Current report
05.12.202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202315:13EDGAR2Form DEF 14A - Other definitive proxy statements
21.11.202323:32EDGAR2Form PRE 14A - Other preliminary proxy statements
14.11.202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202323:02EDGAR2Form 8-K - Current report
13.11.202322:30GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
13.11.202314:35EDGAR2Form 8-K - Current report
09.11.202314:00GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
08.11.202322:05EDGAR2Form 8-K - Current report
07.11.202314:01EDGAR2Form 8-K - Current report
07.11.202314:00GLOBEBioSig Appoints Global MedTech Leader Fred Hrkac as New..
03.11.202321:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03.11.202321:30EDGAR2Form DEF 14A - Other definitive proxy statements
02.11.202313:00EDGAR2Form 8-K - Current report
02.11.202313:00GLOBEBioSig’s New PURE EP™ Subscription Model Adopted by Mayo..
02.11.202312:17EDGAR2Form 8-K - Current report
01.11.202313:35EDGAR2Form 8-K - Current report
01.11.202313:30GLOBEBioSig Adds Five New Patent Awards to 100+ Total Patent..
24.10.202322:30EDGAR2Form PRE 14A - Other preliminary proxy statements
16.10.202323:00EDGAR2Form 8-K - Current report
27.9.202323:01EDGAR2Form 8-K - Current report
15.9.202322:54EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock